These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36466914)

  • 1. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
    Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
    Front Immunol; 2022; 13():918254. PubMed ID: 36466914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
    Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
    Nakamura N; Goto N; Tsurumi H; Takemura M; Kanemura N; Kasahara S; Hara T; Yasuda I; Shimizu M; Sawada M; Yamada T; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2013 Oct; 91(4):322-31. PubMed ID: 23672298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell Leukemia.
    Kato M; Imaizumi N; Tanaka R; Mizuguchi M; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Todoroki J; Karube K; Masuzaki H; Tanaka Y; Fukushima T
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
    Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
    Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
    Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
    Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.
    Purdue MP; Hofmann JN; Kemp TJ; Chaturvedi AK; Lan Q; Park JH; Pfeiffer RM; Hildesheim A; Pinto LA; Rothman N
    Blood; 2013 Aug; 122(6):951-7. PubMed ID: 23814017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.
    Guerrero CLH; Yamashita Y; Miyara M; Imaizumi N; Kato M; Sakihama S; Hayashi M; Miyagi T; Karimata K; Uchihara J; Ohshiro K; Todoroki J; Nakachi S; Morishima S; Karube K; Tanaka Y; Masuzaki H; Fukushima T
    Blood Adv; 2020 Mar; 4(6):1062-1071. PubMed ID: 32196559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative spliced variant of circulating soluble tumor necrosis factor-alpha receptor-2 is paradoxically associated with insulin action.
    Fernández-Real JM; Straczkowski M; Lainez B; Chacón MR; Kowalska I; López-Bermejo A; García-España A; Nikolajuk A; Kinalska I; Ricart W
    Eur J Endocrinol; 2006 May; 154(5):723-30. PubMed ID: 16645020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis.
    Yang N; Huang J; Frits M; Iannaccone C; Weinblatt ME; Rifai N; Shadick N; Bradwin G; Liao KP
    Pract Lab Med; 2019 Aug; 16():e00122. PubMed ID: 31193412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
    Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis.
    Arjmand MH; Moradi A; Akbari A; Mehrad-Majd H
    Cytokine; 2020 Jan; 125():154869. PubMed ID: 31585311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort.
    Marrone MT; Lu J; Visvanathan K; Joshu CE; Platz EA
    Cancer Causes Control; 2021 Aug; 32(8):871-881. PubMed ID: 33999316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of soluble tumor necrosis factor receptor 1 and 2 are associated with survival after ST segment elevation myocardial infarction.
    Befekadu R; Grenegård M; Larsson A; Christensen K; Ramström S
    Sci Rep; 2022 Aug; 12(1):14762. PubMed ID: 36042366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
    Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
    Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
    Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
    Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
    Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
    Front Immunol; 2017; 8():1482. PubMed ID: 29163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.